Reasons to not get over excited about hydroxychloroquine: 1. Early promising therapies often disappoint 2. There are known toxicities & dangerous drug interactions 3. People need these meds for evidence-based indications (eg., RA, SLE) Wait for the studies. Don't hoard.
-
-
That let to doctors trying it, anecdotes, and then registered clinical trials, only two of which have been published, both small, one negative, and one positive but so flawed as to be uninformative. 2/
-
But before even that, in February the Chinese announced that the clinical trial results were "promising" and issued an "expert
#Hydroxychloroquine and#chloroquine to their recommendations for treating#COVID19. Doctors around the world took their word for it and did the same. - Show replies
New conversation -
-
-
And some in vitro experiments that have never panned out in vivo. It seems to come up with every viral outbreak (I remember it from Zika at least). It is very bizarre that people want to reach for drugs like chloroquine, colchicine, ivermectin, etc for these conditions.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
So Isn't that another indication that it might work or at least help?
-
Anecdotal evidence is worthless. So no.
- Show replies
New conversation -
-
-
This Tweet is unavailable.
-
Nothing has been proven yet.
- Show replies
-
-
-
Wait, what? Lupus patients, who already probably take more precautions than the average person because of having an auto-immune disease, don’t get COVID-19, and they decide it’s the medication that was the reason? OMG.
-
I kid you not. That's the origin of the hypothesis. In Wuhan in January, some doctors noted that 80 patients with lupus taking
#Hydroxychloroquine or#chloroquine never got sick with#COVID19. - Show replies
New conversation -
-
-
This Tweet is unavailable.
-
Yes he is. What are you?
End of conversation
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.